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ABSTRACT
Background: Health-related quality of life is becoming an increasingly important issues
associated with HIV disease. Identification of factors that determine health related
quality of life are important in order to better tailor health and social care services, and
there by improve the functioning and well being of people who are living with HIV.
However, little is known about the health related quality of life of people living with HIV
in this region.
Objective: The main aim of this study is to assess health related quality of life and
associated factors among adult people living with HIV/AIDS in South Wollo Zone, North
East Ethiopia.
Methods: An institutional based cross-sectional study was conducted from, June 1-30,
2011, in selected health institution in south Wollo zone, North East Ethiopia. Systematic
random sampling was utilized to select 394 PLHIV; Data on quality of life was collected
by trained nurses through face to face interviews using the Amharic version of the World
Health Organization quality of Life Instrument for HIV clients. Data was entered to EPI
INFO version 2002 and exported to SPSS versions 16.0 for further analysis. Descriptive
statistics, such as mean and standard deviation, were used to summarize the score of
health related quality of life. Independent sample t- test was also used to test mean
difference among different health related quality of life domains. Binary Logistic
regression, multiple Liner regression were used to determine the factors which affects
Health related quality of life of people living with HIV.
Result: Health related quality of life data were available for 394 persons giving a
response rate of 100%. Most of the study(71.1%) participants were ART Naïve while
29.9 % were taking antiretroviral medication .The mean score of  health related quality
of life was 13.61 (SD=+ 2.09) . Nearly half 47.2% of all respondents 144 (52.2%) of the
ART naïve and 42 (35.6%) ART group did have poor quality of life with mean + SD
score 14.3 (SD=+1.7) Vs 13.3 (SD =+ 2.2) ART groups & ART Naïve respectively (tdf
392 = 4.39, P< o.oo1). In the multivariate analysis PLHIV on ART (AOR = 2.77, 95% CI:
(1.61, 4.78)). Those in the 2nd & 3rd income percentiles were (AOR = 2.95, 95% CI:
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(1.17, 7.42) (AOR = 3.68, 95% CI (1.15, 11.78),Have more than 95 % adherence to
ART (AOR: 3.43, 95% CI: (1.52,7.70), Having treatment supporter (AOR = 1.94, 95%
CI,  (1.18, 3.19) and have emotional Care giver (AOR =,95% CI, 2.21 (1.15,4.27) were
predictors of good health related quality of life. On multiple linear regression highest
contribution for quality of life were from environmental domain (B=0.251), Social
relationships (B=0.143) and Physical domain (B=0.137) domains (P <0.001)
Conclusion and Recommendation: Nearly half of the study population is in poor
quality of life. Those who have emotional care giver; income opportunities & good
adherence to ART have demonstrated good quality of life. In all aspects, the problem
prevails in ART naïve group. Clinicians need to provide educational and counseling
programmes for PLHIV and their family members side by side to treatment, assigning
social worker & adherence counselors in ART clinics is highly beneficial .
11. INTRODUCTION
1.1. STATEMENT OF THE PROBLEM
Quality of life is a multi-dimensional construct that refers to physical, psychological and
social aspects of an individual. These are indicators of how well an individual functions
in daily life as well as of how the individual’s perceptions of how health status influences
his or her life (1). I.e. How an HIV patient experiences the disease symptoms and
adapts to the financial and social changes after having been infected is just as important
as disease progression and treatment (2).
Measures of HRQOL are commonly used in determining the effects of medical and
community-based health interventions by comparing the general health of different
Populations and assessing their health needs and increasingly being recognized as
important when comparing   the efficacy of AIDS therapies and assessing the impact of
HIV/AIDS on peoples’ lives (3) .The development of antiretroviral therapy (ART) has
dramatically lowered morbidity and mortality in countries where it is widely available (4).
Many people living with HIV/AIDS (PLHIV) have a better quality life as the result of
increasing availability of antiretroviral therapy (ART). Nevertheless, many patients who
live in sub Saharan Africa the devastating physical effects have been replaced by
psychological conditions including social isolation, condemnation of their family, friends
and society indicating high level of stigma and discrimination. The psychological and
social effects of Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency
Syndrome (AIDS) on patients' quality of life (QOL) have been constantly fluctuating (5).
Globally an estimated 40.3 million people were living with HIV/AIDS by the end of 2010,
with two thirds of the world's burden in sub-Saharan Africa. The estimated 1.3 million
people who died of HIV related illnesses in sub-Saharan Africa in 2009 comprised 72%
of the global total of 1.8 million deaths attributable to the epidemic (4). In Ethiopia alone,
more than 1.2 million people are HIV positive in 2010 of which 520,000 had AIDS.
HIV/AIDS in Ethiopia is a leading cause of death and was responsible for 38% of
2premature mortality by 2010 (6). AIDS also impairs health related quality of life
(HRQOL), which is an important measurable outcome of HIV treatment in the era of
Highly Active Antiretroviral Treatment (HAART), complementing more objective
outcomes such as death (7, 8).
The Health related quality of life has never been investigated among people living with
HIV (PLHIV) in the region; this study therefore aimed at to examine the health related
quality of life and associated factors including life needs among people who are living
with HIV (PLHIV) at different stages of their illness in the north east region of Ethiopia.
31.2. LITERATURE REVIEW
1.2.1. Quality Of Life PLHIV
QOL is a term that is popularly used to convey an overall sense of well-being and
includes aspects, such as happiness and satisfaction with life as a whole. QOL relates
both to the adequacy of material circumstances and to personal feelings about these
circumstances with overall subjective feelings of well-being that is closely related to
morale, happiness, and satisfaction. QOL has recently been scientifically-defined and it
has been considered synonymous with health status, function status psychological well
being, happiness with life, satisfaction of needs, and assessment of one’s own life (21)
The benefit of antiretroviral therapy has been documented elsewhere. The varieties of
treatment options available have decreased opportunistic infections, morbidity and
mortality. Social, emotional and informational support on the other hand have
decreased stigma, increased, disclosure and demand for voluntary counseling and
testing and have given better clinical benefit in terms of Virological suppression having
the knowledge of these undeniable advantages, what other negative effects do exist?
How were they measured (9)
Survey on living conditions and quality of life among PLHIV conducted in Norway, in
2002; the general income of PLHIV is on the same level as the general population, but
44% of the respondents compared with 9% of the general population have problems
covering daily expenses. The majority is open about their HIV status towards at least
one person, but there has been also a closed world. More than 1/3 of the respondents
were abstain for sex and experience less physical contact. The physiological condition
is worse than in the average population. PLHIV complain bi-effects of the HAART and
want to strengthen their immune system through alternative means. There is a demand
for a more holistic approach in health services (10).
A cross-sectional study to investigate Quality of life in people living with HIV/AIDS in
Lebanon by Sarah Abboud et.al  showed that the mean age of respondents was 38
4years (SD+9.93). The mean QOL-HIV score was 176.85, Norway, 2002 with the highest
scores for the cognitive functioning, social functioning, and medical care; the lowest
domain scores were for financial status, sexual functioning, and mental health. A single
item measuring overall QOL was rated by 47.5% as neither poor nor good. Mean stigma
score was 2.05 (SD_0.62) and mean HIV Symptom Index score was 0.6. Prevalence of
symptoms and perceived stigma were negative predictors of QOL, being married was a
positive predictor of QOL (11).
Another study among HIV- Positive & HIV negative clients in Malawi showed HIV-
positive patients had significantly lower physical functioning (p_0.0365), mental health
(p_0.001),social functioning (p- 0.0001), and mental component summary (p_0.0069)
scores than HIV-negative patients. Further, WHO Stage III HIV patients had significantly
lower vitality (p_0.0439) and mental health (p_0.0022) scores than WHO Stages I and II
patients. AIDS patients, as determined by CD4 count, had significantly lower bodily pain
(p_0.0423) and physical component summary (p_0.0148) scores than non-AIDS, HIV-
positive patients (12).  A similar finding was observed in Ghana study all Physical
mental & social functioning were lower for HIV Positives than their nebougher and
families (p<0.005) (13). Unlike the two studies a cross-sectional study done in Nigeria
show the overall QOL mean scores in the three domains were similar: psychological
health, 15.0±2.8; physical health, 15.2±2.5; and spirituality/religion/personal beliefs,
15.7± 3.4. Lower QOL mean scores were observed in social relationships (13.2±2.5)
and environment (13.1±1.9) domains. A significant difference in mean QOL scores in
the level of independence domain was observed among women (14.4±1.9) compared to
men (13.9±1.7; p=0.028) (14)
A cross sectional  study which was done among PLHIV and HIV negative  in Rwanda
showed Scores in the psychological domain and overall quality of life and health
satisfaction were high in the self-reported HIV negative and showed statistically
significant difference (p<.01). Compared to the PLHIV scoring for psychological domain
is improved and possibly reflects a more “stable” psychological state with higher quality
of life and health satisfaction in the healthy group (15) similarly a study which was done
in Uganda on self-reported quality of life and health status among HIV-infected women
5and a comparison sample of HIV-uninfected women showed HIV positive women
reported lower scores than HIV-negative women for general health perceptions,
physical functioning, pain, energy, role functioning, social functioning, mental health and
overall quality of life (p all < /0.01) (16)
A cross sectional study by Amare etal in selected hospitals in Oromia region to see the
Tuberculosis and HIV co-infection and its impact on quality of life showed that after
controlling for potential confounding variables like age, sex, occupation, CD4
lymphocyte count, WHO staging and social support, co-infected patients had a lower
mean/median score in all domains indicating poor QOL. Mean scores for physical
health, social relationship and environmental health among co-infected patients were
13.26(SD = 4.3), 12.15(SD = 3.1) and 11.7(SD = 3.6) respectively (17).
1.2.2   Factors Affecting Quality of life among PLHIV
A cross-sectional study on health-related quality of life in persons with HIV infection:
results from a multi-site interview project in USA showed factors associated with lower
HRQOL scores included older age, female sex, black or Hispanic race/ethnicity,
injection drug use, lower education and income, no private health insurance, and lower
CD4 count. In multivariate analysis, lower CD4 count was the factor most consistently
associated with lower HRQOL. Taking antiretroviral medication was not associated with
differences in HRQOL regardless of Cd4 count (18) while a study that was done among
367 patients in Brazil showed the use of antiretroviral drugs was associated with worse
QOL in the domain of the level of independence (P = 0.016). Being unemployed were
associated with a worse QOL (P < 0.05) in five out of six domains; the only exception
was the domain of spirituality (P > 0.05). Among the factors assessed, the
socioeconomic aspects were most significant in determining the HRQOL of the patients
studied (19).
A cross-sectional survey  on factors influencing quality of life of people living with HIV in
Estonia by Kristi Rüütel" et al demonstrated  Good overall quality of life reported by
42.6% (95% CI: 38.0–47.2%) regarding factors the study showed  female gender (p =
60.03); age under30 years  (p = 0.009); living in the capital city ( p = 0.0001); being
employed or studying (p < 0.0001); being legally married (p = 0.004); being aware of
their infection for less than 12 months (54% vs. 41%, p = 0.02); having no HIV-related
symptoms, (p < 0.0001); and CD4 count above 300 cells/mm3, ( p = 0.0003)  while In
Multivariate analysis in this study, being currently employed or studying (AOR: 2.27,
95% CI: 1.18–4.38) and the absence of HIV-related symptoms (AOR: 2.31, 95% CI:
1.24–4.29) were identified as independent predictors of good QOL (20). Similarly a
cross- sectional study done In Iran on health related quality of life showed Gender,
marital status, level of education, CD4 count, and clinical stage of the disease, had a
significant effect on the quality of life of the patients. In multivariate analysis, the most
important    predictor of the quality of life was clinical stage of the disease (21)
Another study in India showed women are more affected than men in all QOL
dimensions. Similarly, comparisons between symptomatic patients and AIDS patients
showed significant correlation in case of domains of physical activities, daily activities,
social activities and food intake and appetite (P=0.015, 0.010, 0.003 & 0.008
respectively) (22). Unlike the above study, a cross sectional  study  done among PLHIV
and HIV negative  in Rwanda  show HIV positive patients at stages III and IV had their
physical and environmental dimensions negatively affected compared to early stages. In
early stages, those in stage II had their psychological dimension impaired compared to
stage I. In stages III and IV, overall quality of life was impaired as well as impairment of
physical and environmental health. Scores in the physical domain also higher in the
younger age group with a statistically significant difference (p<.001). This would suggest
more physically robust health in the younger age group compared to the more elderly
HIV patients who may have increasing physical disability (15)
Similarly a cross sectional study conducted in Oromiya Regional state, Ethiopia among
467 HIV patients and 124 TB/HIV co-infected patients. on quality of life indicate
depression, having a source of income and family support were strongly associated with
most of the QOL domains. Aged ≤35 had better mean scores for scales of Physical,
limitation in role due to physical health and physical-health component summary score.
7Those aged 36 and above scored better for scales of general, Social, and, mental
health .In co-infected patients, individuals with depression were 8.8 times more likely to
have poor physical health as compared to individual who had no depression ,OR =
8.8(95%CI: 3.2, 23). Similarly those without family support were 1.5 more likely to have
poor physical health in co-infected and mono-infected patients Similarly, depression,
family support and having a source of income were strongly associated with
psychological health Among co-infected patients, depressed individuals were 5 times
more likely to have poor social relationships as compared to individual without
depression [OR = 5.3, (95%CI: 2.3, 14.2)]. Depression was also associated with poor
quality of the social QOL domain among HIV patients OR = 2.4, (95%CI: 1.6, 3.6)].
Family support was associated with social relationships in HIV patients with and without
co-infection (P < 0.001). Educational status was significantly associated with the
environmental QOL domain. Literate individuals were 4 times more likely to have good
QOL as compared to illiterate ones, OR = 4, (95% CI: 2.3, 7.3) (17)  similarly another
study  conducted  in  selected hospitals  in  southern Ethiopia show Marital  and
education status were shown to have the same effect on the measured parameters.
Married participants as well as those that had attained a secondary school education
had better scores than the unmarried and uneducated participants in all scales except
for social and mental health (23)
81.3. JUSTIFICATION OF THE STUDY
In Ethiopia, more than 1.2 million people are HIV positive in 2010, of which 520,000 had
AIDS [19]. HIV/AIDS in Ethiopia is the leading cause of death and was responsible for
38% of premature mortality by 2010 In Amhara region, more than 379,096 people are
living with HIV/AIDS in 2010 that takes urban rural prevalence of 9.8% & 1.4%
respectively. Hence forth, the region is among the highly affected regions in Ethiopia.
Many of  these HIV positive  patients struggle with numerous social problems such as
stigma, poverty, depression, substance abuse, and cultural beliefs which can affect their
quality of life not only from physical health aspect, but also from mental and social
health point of view and cause numerous problems in useful activities and interests of
the patients. Unless a cure is found or a life-prolonging therapy can be made more
widely available, the majority of people living with HIV or AIDS will be continuing a
victim of this disease with serious impact on their quality of life. Determination of factors
affecting HRQOL can help to select the best method of therapy and doing the best to
treat these patients. Therefore, the efficacy of HIV/AIDS care is increased.
Health related quality of life (HRQOL) has never been investigated among people living
with HIV and AIDS (PLHIV) in the region. By examining HRQOL and associated factors,
this study therefore will provide valuable base line information on these issues in the
region. In addition it will also play a great role in devising mechanisms regarding the
care needed for people living with HIV/AIDS to improve their lives. Moreover, it will have
important input for devising strategy and clinical guideline (management protocol
development) at ART treatment sites in line with the ART treatment guideline.
92. OBJECTIVES
2.1. GENERAL OBJECTIVE
To assess health related Quality of life and associated factors among adult people living
with HIV/AIDS in South Wollo Zone, North East Ethiopia, 2011
2.2. SPECIFIC OBJECTIVES
 To determine level of health related  quality of life of adult people living with
HIV/AIDS
 To identify factors associated with health related quality of life among adult people
living with HIV/AIDS.
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3. METHDOLOGY
3.1. STUDY DESIGN
An institutional based cross sectional study was conducted in South Wollo zone, North
East Ethiopia.
3 .2 STUDY AREA AND PERIOD
The Study was conducted in South wollo zone, particularly in Dessie Hospital, Dessie
Health Center & Kombolcha Health Center ,  south wollo zone is one of  the 11 Zones in
the Amhara Region this Zone has a total population of 2,870, 476 of those 1,423,756
were male and 1,446,720 were female (24)
About 45,334 People are ever enrolled for HIV/ AIDS care & treatment of those 15,336
currently taking ART.  All the health centers are giving VCT service but   ART service is
provided in one referral hospital, two district hospitals and fifteen Health centers.
Dessie HC, Kombolcha HC & Dessie Referal Hospital were selected for this particular
study.  The reason for choosing this one hospital and the two health centers were
because of high numbers of patients were being enrolled (62% of PLHIV) enrolled in
these facilities. Monthly these three health institutions provide care & treatment for an
average of 2377 ART and ART Naive clients. The study was conducted from June 1-30,
2011.
3.3 SOURCE POPULATION
PLHIV who were attending clinical care & treatment follow up at Health facilities in
south Wollo zone.
3 .4 STUDY POPULATION
PLHIV who were attending clinical care & treatment follow up at Dessie Hospital,
Kombolcha Health center & Dessie Health Center.
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3.5. INCLUSION & EXCLUSION CRITERIA
The Inclusion Criteria
 All PLHIV come for clinical care & treatment follow up were included in the study.
The Exclusion criteria
Severe psychiatric or cognitive problems
Seriously ill
Started ART in less than 3 months were excluded
3.6. SAMPLE SIZE AND SAMPLING TECHNIQUE
3.6.1. Sample Size Determination
After computing for all the variables the minimum sample size is calculated as 394
subjects by considering normal distribution using sample size calculation for single
mean for cross-sectional study and based on the following formula and assumptions
(including 15% non response rate).
Hence physical domain provides the maximum sample size and it is used to determine
the sample size calculation for QOL.
Variable Standard
Deviation (σ)
Confidence
interval (CI)
Standard
error (SE)
Minimum
sample size
Physical Health 2.8 95% 0.3 % 334.65
Psychological Health 2.5 95% 0.3 % 266.78
Social relationship 2.8 95% 0.3 % 334.65
Environmental Health 2.7 95% 0.3 % 311.17
Level of independence 2.8 95% 0.3 % 334.65
Spiritual health 2.8 95% 0.3 % 334.65
2
2 





SE
z
n 
12
n = required minimum sample size
σ= 2.8 is estimate of population standard deviation (population standard deviation
taken from the study done in oromia region (17)
Z2α/2 = 1.96 is z score for selected confidence level (CI at 95%)
SE = standard error of the mean (margin of error desired 0.3)
Allowing for a contingency due to non-response (a rate of 15%)
n= (1/(1-0.15)) x 335= 394 PLHIVs
The final sample size was 394 PLHIVs (118 ART& 276 ART naive)
3.6.2. Sampling Techniques
Initially the Hospital and health centers are selected based on the high case loads they
have. Then a systematic random sampling technique was employed after proportional
allocation of the calculated sample size. Every 6th ( K= 2377/394 ) consecutive adult out
patients who were receiving antiretroviral treatment (at least for three months) and ART
Naive  clients on follow up and those who were able to give informed consent during
the study period was  the study subjects. The sampling interval K= 6 was selected
based on the monthly number of patients compared with the sample size .The first
sample was selected by lottery method from numbers one to six.
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Fig.1. Schematic presentation of the sampling technique
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3.7. VARIABLES
 Dependent variable: Health Related Quality of life (HRQOL)
 Explanatory variables for the main outcome variable;
 Socio demographic characteristics: - Residence , Age, Sex, Marital Status,
Religion, Availability of paid job , Monthly income and Educational status
 Clinical variables
 WHO clinical stage of the disease
 HIV helper cell count (CD4+) counts
 Prophylactic    medication
 Duration of treatment for HAART
 Duration for knowing HIV status
 Behavioral variables
 Adherence to dose of ARV
 Adherence to treatment (follow up) schedules
 Presence of financial/material support
 Physical, emotional and treatment care giver
15
3.8. DATA COLLECTION TECHNIQUE AND MATERALS
A structured pre-tested standardized, but locally adopted World Health Organization's
quality of life HIV bref instrument (WHOQOL-HIV) was used for data collection. The
WHOQOL-HIV bref consists of 29 facet which are subsumed in six domains and two
general item that measures the overall QOL & general health perceptions, with each
item using a 5-point Likert scale with 1 indicates low or negative perceptions & five
indicating better quality of life. Some facets (pain and discomfort, negative feelings,
dependence on medication, concerns about the future, bodily image and appearance,
death and dying) are not scaled in a positive direction, meaning that for these facets
higher scores do not denote higher quality of life. These need to be recoded so that high
scores reflect better QoL. The 29 items are distributed in six domains of QOL as follows:
Physical health, psychological health, level of independence, social relationships
environment, and spirituality/religion/personal beliefs .The physical health domain
measures pain and discomfort, energy and fatigue, and sleep & rest and symptom of
PLHIV. The psychological health domain measures positive feelings, thinking, learning,
memory and concentration, self esteem, bodily image and appearance, and negative
feelings. The level of the independence domain measures mobility, daily life activities,
dependence on medications or treatments, and work capacity. The social relationships
domain includes personal relationships, social support, and sexual activity. The
environment domain measures physical safety and security, home environment,
financial resources, health and social care, accessibility and quality, opportunities for
acquiring new information and skills, participation in and opportunities for recreation and
leisure activities, and physical environment (pollution, noise, traffic, climate, and
transport). The spirituality/religion/personal beliefs domain measures forgiveness and
blame, concerns about the future, and death and dying.
First facet means were examined; Facet scores are the mean of the four items in each
facet. Domain scores are obtained by adding the facet means in the respective domain,
dividing by the number of facets in that domain, and multiplying by 4, to transform to
16
domain score of HRQOL ranged from 4 (minimum) to 20 (maximum), with higher scores
indicating a better QOL  and to be   comparable with WHO HRQOL 100.
Data on socio-demographic and care & support characteristics was collected by pre
tested questionnaire. Clinical characteristics (CD4 count, WHO staging, prophylaxis
drug for opportunistic infections) were identified from patient’s records. Internal
consistency reliability scale was examined by using Cronbach’s α and it was calculated
for each of the six dimensions of HRQOL and relationship between various domains of
the quality of life was assessed by Pearson’s correlation coefficient. Cronbach’s α of 0.7
or above was considered acceptable.
Three supervisors and 6 nurse data collectors were assigned for the interview and data
collection (one supervisor and two data collectors at each health facilities) trained for
two days on how to facilitate & collect the data. Data collection was conducted for one
month starting from Jun 1-30, 2011. During the data collection, respondents were
arranged in a manner that could ensure their privacy during the interview.
.
.
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3.9. DATA MANAGEMENT AND QUALITY CONTROL MEASURES
The instrument is derived from standard data collection tools prepared by WHO. It was
pre-tested for consistency of responses by taking 5% of the sample size, conducted in a
similar population in Boru Meda Hospital. Necessary modifications were made
accordingly before use.
Two days training was given to supervisors & data collectors on instructions on how to
fill the questionnaire. Additionally, it was made clear to data collectors by preparing data
collection manual.
The PI & supervisor were closely followed the day-to-day data collection process and
ensure completeness and consistency. All incomplete questionnaire was returned back
daily. To maintain validity the World Health Organization's quality of life HIV (WHOQOL-
HIV) questionnaire was translated to Amharic according to local setting and back
translated to English by principal investigator and language experts. Double data entry
was made to ensure quality of data.
3.10. DATA PROCESSING AND ANALYSIS
All returned questionnaires were checked for completeness and consistency of
responses manually. In line with this, Data was coded and entered in to EPI INFO
version 2002 and export to SPSS version 16 for analysis.
Descriptive statistics, such as mean and standard deviation were used to summarize
the score of HRQOL. For the analysis of statistical differences between the mean
scores of HRQOL for dichotomous variables, the student t-test was used. The level of
statistical significance was set at P<0.05; then multivariate analysis was used to
determine the presence of statistically significant associations between the dependent
variable (HRQOL) and the independent variables.
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3.11. OPERATIONAL DEFINIATION
 Quality of Life - an individual's perception of their position in life in the context of the
culture and value systems in which they live and in relation to their goals, expectations,
standards and concerns. By taking the mean (if the distribution is found to be normal) or
the median, (if the distribution is found to be skewed) QOL was   dichotomized as poor or
good.
 Good quality of life - Participant who score greater than or equal to the mean or
median value of HRQOL  define as having good quality of life
 Poor Quality of life- - Participant who score  less than the mean or median value of
HRQOL  define as having poor  quality of life
 Adherence- the extent to which a patient follow medical instruction
 Good Adherence -is greater than or equal to 95% of adherence (Missing less than or
equal to 2 doses out of 30 or 3 doses out of 60 doses).
 Fair Adherence -is between 85- 94% of adherence (Missing 3 to 5 doses out of 30
or 3 to 9 doses out of 60 )
 Poor Adherence- is less than 85 % of adherence (Missing greater than 6 doses
out of 30 or greater than 9 doses out of 60).
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3.12. DISSEMINATION OF RESULTS
Final result of this paper will give to school of public health of University of Gondar. The
results of this paper will also be disseminated to all stakeholders including the FMOH,
Amhara Regional health Bureau, South wollo zone Health department, to the health
institutions & other NGOs and GOs.
An Attempt will also make to present the paper at conferences and to publish on
reputable research Journal.
4.  Ethical Consideration
Ethical clearance letter was obtained from University of Gondar Institutional Review
Board (IRB) and Officials at different levels, south Wollo health department and the
selected health institutions were communicated through formal letters from UOG.
Informed consent was obtained from all study participants by reading written Informed
consent form after clearly told about the purpose and objective of the study and the
variety of information needed. Prior to starting of the interview all the study participants
were assured that the data was anonymous, names or any personal identifiers were not
recorded. Participants were given the chance to ask any doubt about the study and
made free to refuse or stop the interview at any moment they want.
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5. RESULT
5.1. Socio-demographic Characteristics of the Respondents
A total of 394 PLHIV were interviewed and HRQOL data were available for all 394
persons, giving a response rate of 100%. Nearly 61 % of the respondents (62.6%of the
ART Naïve & 55.9% ART groups) were females with male to female ratio of 0.40:0.60.
Seventy four percent of respondents were Urban by residents and majority were age
less than 49 years (96.4%) with a mean +SD age of 32.7 + 7.8 years. Of this nearly 37
% of respondents were young people ages less than 30 years. Only 4.7% of ART naïve
groups had college or university education while 26. 3 % of ART group had. Overall
11.2% PLHIVs had either college or university educations while 19.8% & 23.4% are
unable to read & write   and read & write respectively. The majority 61.9% of adult
PLHIV were ever married at the time. About 77.4% had some job for pay. Of those who
had job for pay 29.8 % have income of less than 400 Ethiopian Birr with Mean +SD
income =766.5+592.5; minimum 50 birr & maximum 4000 birr per month .The socio-
demographic features of the study subjects are shown in (Table 1 ).
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Table 1:   Distribution of adult PLHIV by Socio demographic characteristics and
treatment status, South Wollo Zone, North east Ethiopia, June 2011
variable ART Naïve
n = 276 (71.6%)
On ART
n= 118(29.9%)
Total
n=394
Mean + SD
Age 19-24 31   (11.2%) 7      (5.9 %) 38      (9.6%) 32.7 + 7. 8 years
25- 29 76   (27.5%) 30 (25.4%) 106    (26.9%)
30-34 59   (21.4%) 31 (26.3%) 90     (22.8%)
35-39 57   (20.7%) 25    (21.2%) 82      (20.8%)
40-44 33   (12%) 11    (9.3%) 44      (11.2%)
45-49 13   (4.7%) 7     (5.9%) 20        (5.1%)
>50 7    (2.5%) 7      (5.9%) 14         (3.6%)
Sex
Male 103 (37.4%) 52    (44.1%) 155     (39.3%)
Female 173 (62.6%) 66       (55.9%) 239      (60.7%)
Residence
urban 203 (73.6%) 90       (76.3%) 293       (74.4%)
rural 73   (26.4%) 28       (23.7%) 101        (25.6%)
Religion
Muslim 139   (50.4%) 65   (55.1%) 204 (51.8%)
Christians 137   (49.6%) 53  (44.9%) 190 (48.2%)
Marital status
Never married 35   (12.7%) 12 (10.2%) 47          (11.9%)
Married 167 (60.5%) 77(65.3%) 244        (61.9%)
Divorced 44    (15.9%) 19(16.1%) 63         (16.0%)
Widowed 30   (10.9%) 10 (8.5%) 40         (10.2%)
Education
Illiterate 68 (24.6%) 10 (8.5%) 78        (19.8%)
Read & write 50 (18.1%) 42(35.6%) 92         (23.4%)
Primary 62 (22.5%) 16(13.6%) 78        (19.8%)
Secondary 83 (30.1%) 19 (16.1%) 102        (25.8%)
College/
university
13 (4.7%) 31
(26.3%)
44         (11.2%)
Ethnicity: Amhara 253   (91.7%) 111 (94.1%) 364      (92.4%)
Tegrie 16    (5.8%) 4 (3.4%) 20          (5.1%)
Others 7     (2.5%) 2 (1.7%) 10       (2.5%)
Have a job for pay
Yes 210 (76.1%) 95 (80.5%) 305       (77.4%)
No 66   (23.9%) 23(19.5%) 89         (22.6%)
Income
Low Income (<
400 ETB) 26 (27.4%) 65(31.0%)
91          (29.8%)
Medium Income
(401-999 ETB 50 (52.6%) 104(49.5%)
154        (50.5%)
High  Income (> 1000
ETB 19 (20.0%) 41(19.5%)
60(19.7%)
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5.2. Reliability & validity of the instrument (Amharic version of
WHOQOL-HIV bref)
To measure internal consistency, a reliability analysis was done and the Cronbach's
alpha was calculated for each domain of the instrument.. In our finding Cronbach’s
alpha was (α = 0.86) which (ranges from 0.82 for environmental to 0.86 for social &
spiritual domains) which exhibits high internal consistency. All scores of domains were
correlated with the total measure of the quality of life significantly (P<0.05). The most
significant positive correlation was observed for the Psychological & Independence
Domains (r2= 0.72 each) with the total score. However, a weak correlation was
observed between overall score & spiritual health (r2= 0.52) P< 0.01 (Table 2).
Relationship between various domains of the quality of life (inter domain correlation)
was assessed by Pearson’s correlation coefficient at (95% CI two tailed test).   All
scores of domains were correlated with each other and of the quality of life significantly
(P<0.01). The most significant positive correlation was observed between the social and
environmental domains (r2= 0.63 P< 0.01) while the least was observed between social
and spiritual domains (r2= 0.30 P< 0.01) (Table 3).
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Table 2: Internal consistency of the Amharic version of the WHOQOL-HIV
questionnaire
QOL- Domain Mean (SD)
Score
Cronbach’
sα
Number
of items
Correlation
coff. (r2)with
the total
score
Test of
significanc
e at df= 6
Physical 15.12 (3.05) .83 4 .68 P=(.000)
Psychological 13.60 (2,49) .83 5 .72
Independence 13.68 (2.73) .83 4 .72
Social 12.64 (3.13) .86 4 .58
Environmental 13.13(2.71) .82 8 .75
Spiritual 14.64(2.60) .86 4 .51
Total 13.61(2.09) .86 29
Table 3: Correlation between domains of the Amharic version of the WHOQOL-HIV
questionnaire**
Physical Psychological
Independen
ce Social
Environm
ental Spiritual
Physical 1.00
Psychological .60 1.00
Independence .63 .60 1.00
Social domain .39 .48 .49 1.00
Environmental .57 .65 .61 .64 1.00
Spiritual .48 .47 .42 .30 .39 1.00
** Correlation is significant at the 0.01 level (2-tailed)
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5.3. Clinical and Care & support characteristics of adult PLHIV
Most of the study populations were ART Naïve (70.1%) while 29.9 % were taking
antiretroviral medication. Nearly 14% of ART group taking antiretroviral medication did
have a CD4 count of <200, compared to 55.9% with a CD4 count of 200–500(Fig 1&Fig
2). Majority of the ART Group were aware of their HIV status between 1-5 years while
nearly half 49.3% of the ART Naïve group enrolled to ART care in less than 12 months.
Regarding financial support only 15 %   (15.6 % of the ART naïve & 13. 6% of the ART
group have got financial support from different organization (Table 4).
Fig-2: Distribution of PLHIVs by Fig-3: Distribution of PLHIVs by
WHO clinical staging & treatment status,                CD4 T lymphocyte count & treatment
South Wollo Zone, NE Ethiopia, June 2011            status, south Wollo zone NE Ethiopia,
June, 2011.
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Table .4:  Distribution of PLHIV by clinical, care & Support characteristics and
treatment status, South Wollo Zone, NE Ethiopia, June   2011
Clinical  variables ART Naive
n = 276 (71.1%)
On ART
n= 118(29.9 %)
Total
n=394
Currently On opportunistic
disease prophylaxis drug
Yes 188   (68.1%) 91(77.1%) 279 (70.8%)
No 88     (31.9%) 27(22.9%) 115 (29.2%)
Duration of  knowing HIV
status
< one year 136(49.3%) 7(5.9%) 143 (36.3%)
1-5 year 120(43.5%) 86(72.9%) 206 (52.3%)
>5years 20 (7.2%) 25(21.2% ) 45(11.4% )
Physical care giver
yes 111(40.2% ) 45 (38.1%) 156(39.6%)
no 165(59.8% ) 73 (61.9%) 238(60.4%)
Emotional care giver
yes 40 (14.5%) 27(22.9%) 67 (17.0%)
no 236(85.5%) 91(77.1%) 327 (83.0%)
Treatment buddy
yes 122(44.2%) 62 (52.5%) 184(46.7%)
no 154(55.8%) 56(47.5%) 210 (53.3%)
Financial Support
yes 43 (15.6%) 16 (13.6%) 59 (15.0%)
no 233 (84.4%) 102- 86.4% 335(85.0%)
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5.4. Level of health related quality of life of adult PLHIV
Analysis was done to determine the 6 domains that measures HRQOL of PLHIV, Accordingly
nearly 60 % of respondents claimed that they satisfied regarding their own overall health with
mean +SD score of (3.67+0.91). Moreover only 34.5 % of respondents were not bothered about
their physical change (mean + SD 3.82+1.12). The mean +SD transformed HRQOL physical
domain score for the study participant were 15.2 +3.05 & there exists a mean difference
between ART & ART Naïve Groups where the ART naive mean +SD domain score 14.77 +3.13
while ART groups have  Mean +SD=15.94+2.68 ,P<0.001 (Table 5). Additionally PLHIV on ART
and ART Naïve Groups where better satisfied in terms of spiritual domain (i.e. Forgiveness and
Blame, Concerns about the Future, & -+Death and Dying) with mean + SD score (15.41+2.81)
for both groups (Table 5).
PLHIV also express they are less satisfied with the social domain that includes Personal
relationships, Social support, Sexual activity &Social Inclusion which shows an individual’s
perception of his/her relationships with self, family and friends and the ability to carry out his/her
role in the community.  Mean +SD domain score for this domain were (12.64+3.13) for all
respondents and 12.43+3.16 and 13.13+3.0 for ART naïve & on ART groups   respectively
(P=0.42). Finally overall QOL was computed and nearly half 47.2% of all respondents (144
(52.2%) of ART naïve Vs 42(35.6%) on ART did have poor quality of life. Fig 4 the box &
whisker plot demonstrates a significant difference observed in total quality of life among PLHIV
on ART  & ART Naïve group with mean+ SD (14.3 +1.7  Vs 13.3+ 2.2 ) respectively (t df 392 =
4.39, P <o.oo1).
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Table 5: Health related quality of life score by domain & treatment status in South
Wollo Zone, North East, Ethiopia, 2011
Domain Facets/ Items Mean Facet
Score (Min
1 & Max 5
MEAN +SD Total
MEAN +SD
t P
valueART ART NAÏVE
Domain I Physical 15.94+2.68 14.77+3.13 15.12 +3.05 3.55 .000Pain and discomfort 2.13Energy and fatigue 3.62Sleep and rest 3.81Symptoms of PLHIV* 2.18
Domain II Psychological 14.42+2.3 13.25+2.5 13.6+2.49 4.37 .000Positive feelings 3.54Learning, & Concentration 3.43Self-esteem 3.70Bodily image and appearance 2.78Negative feelings 3.55
Domain III:  Level of Independence 14.56+2.7 13.30+2.7 13.6+2.73 4.28 .000Mobility 3.96Activities of daily living 3.96Dependence on medication 3.44Work capacity 3.81
Domain IV: Social Relationships 13.13+3.0 12.43+3.16 12.64+3.13 2.04 .042Personal relationships 3.58Social support 3.09Sexual activity 3.01Social Inclusion 2.96
Domain V: Environment 13.77+2.47 12.86+2.8 13.13+2.471 3.06 .002Physical safety and security 3.39Home environment 3.35Financial resources 2.68Health &  social care: accessibility &quality 3.90Opportunities for information & skills 3.10Opportunities for recreation 2.98Physical environment 3.40Transport 3.47
Domain VI Spirituality &  Personal Beliefs 15.41+2.81 15.41+2.81 14.64+2.6 3.92 .000SRPB 3.35Forgiveness and Blame 2.39Concerns about the Future 2.35Death and Dying 2.07
Overall quality of life & general health
perceptions
3.61
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There was a significant difference observed in total quality of life among PLHIV on ART
& ART Naïve group with mean + SD (14.3 +1.7 Vs 13.3 + 2.2 respectively (t df 392 =
4.39, P <o.oo1).
Total QOL by treatment status
Fig .4 . Box and whisker graph shows mean total QOL score of PLHIV by treatment
status, South Wollo Zone, North East, Ethiopia, June 2011.
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5.5 Determinants of health related quality of life
5.5.1 PLHIV Socio-demographic Characteristics
On t test analysis to see the relationship between socio-demographic characteristics &
QOL domains, a significant difference in mean HRQOL between PLHIV who resides in
urban areas than rural, in the four domains except spiritual domain.  Younger PLHIV
(age <30) have higher mean HRQOL score than their older counterparts in all HRQOL
domains (P<0.5). Literate respondents have better mean HRQOL score than those who
can’t read and write (P<0.05). Social domain was affected by all socio demographic
characteristic. For spiritual domain, mean difference was only observed for age,
younger PLHIV have lower mean HRQOL than their older counterparts (tdf, 392 =2.2,
(P=0.002). Gender difference were only affect social domain QOL (tdf, 392 =3.14,
(P=0.007) (Table 6).
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Table:6 Comparison of mean HRQOL scores of PLHIV on physical, psychological,
social relation, environmental and Spiritual by their socio-demographic
characteristics, South Woll Zone, NE Ethiopia, June, 2011
Variable Catego
ry
Nu
mbe
r
Physical Psychological Social Environmental Spiritual
Mea
n
SD t Mea
n
S
D
t Mea
n
S
D
t Me
an
S
D
t Mean SD tResidence rural 101 14.2 3.1 4.25** 12.7 2.6 4.4** 11.2 3.1 5.4** 11.4 2.5 8.2** 14.3 2.5 1.4a
Urban 293 15.5 2.9 13.9 2.4 13.1 3.0 13.7 2.5 14.7 2.6Sex Male 155 15.1 2.9 0.2a 13.6 2.2 0.2a 13.3 2.7 3.14* 13.4 2.4 1.3a 14.5 2.3 1.1aFemale 239 15.2 3.1 13.6 2.7 12.3 3.3 13.0 2.9 14.8 2.8
Age 19-29 144 15.7 3.0 2.7* 13.9 2.5 2.06* 13.1 3.1 2.12* 13.5 2.6 2.1* 15.0 2.6 2.2*
30-67 250 14.8 3.1 13.4 2.4 12.4 3.1 12.9 2.7 14.4 2.6
Education Can’t Read &write 110 14.5 3.0 2.5* 13.0 2.7 2.9* 11.5 3.2 4.4** 11.9 2.4 5.8** 14.2 2.8 2.0a
Read &write 284 15.4 3.1 13.8 2.4 13.1 3.0 13.6 2.7 14.8 2.5
Marital
status
Single 150 15.1 3.1 0.13a 13.5 2.8 0.4a 11.5 3.2 6.2** 12.9 3.2 1.6a 14.5 2.8 0.7a
Married 244 15.1 3.0 13.6 2.3 13.4 2.8 13.3 2.8 14.7 2.4
Monthly
Income
>= 650
139 15.1 3..2
.42 a
13.63 2.5
0a
13.5 2.8
3.6**
13.7 2.8
2.5*
14.6 2.5
.45 a
<650
166 15.3 3.1 13.63 2.5 12.3 3.0 1.2.9 2.6 14.8 2.8
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5.5.2 PLHIV Clinical & treatment Characteristics
Among PLHIV, role limitation due to physical problems, environmental health (that is
access to treatment, having financial resource & home security etc…) and mental health
scores had the greatest differentials between the advanced and early stage patients.
Stages I and II patients had higher mean HRQOL indicator scores than advanced stage
patients based on abstraction from clinical records (tdf=392=2.1 , P= 0.037) and (tdf=392
=2.97.0 , P= 0.003) respectively. In a univariate analysis, the factors which significantly
increased the likelihood of good QOL in the domains, Psychological, environmental
included, adherent to HAART as defined by adherence >95% were significantly
associated with satisfaction in psychological domain (t df=392=3.6, P= 0.000). Moreover,
duration of knowing HIV status increase the likelihood of having higher satisfaction in
health related quality of life. Those acutely aware of their HIV status in less than 12
months were less likely to be satisfied with their physical psychological & spiritual health
(P<0.05).
However, CD4 count above 200 cells/mm3, based on abstraction from clinical records
were not a factor to increase quality of life (p> 0.05) and the t-score for duration of
HAART were not analyzed (only the mean difference is shown) ,Hence the model fail to
explain the difference  (Table 7).
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Table7: Comparison of mean HRQOL scores of PLHIVs on physical psychological,
social relation, environmental and spiritual domain by their Clinical parameters,
June 2011, S. Wollo Zone, NE Ethiopia, june2011.
Variable Catego
ry
Nu
mbe
r
Physical Psychological Social Environmental Spiritual
Mea
n
SD t Mea
n
S
D
t Mea
n
S
D
t Me
an
S
D
t Mean SD t
PLWHIVs
WHO
Stage
Stage 3 &
4 40 14.7 3.2
.8 a
12.8 2.9
2.1*
11.6 3.1
-.2*
11.9 2.6
3.0*
14.1 2.9
1.3 a
Stage 1 &
2 354 15.2 3.0 13.7 2.4 12.8 3.1 13.3 2.7 14.7 2.6
Current
CD4 Count
<=199 42 14.7 3.1 1.0
a
13.5 2.9 .4
a
11.9 3.0 1.5
a
12.9 3.0 .7
a
14.7 2.8 .3
a
>=200 352 15.2 3.0 13.6 2.4 12.7 3.1 13.2 2.7 14.6 2.6
Duration of
HIV Status
awareness
< 12
months 143 14.6783
3.027
11
2.2*
13.208
4
2.7
068
9
2.4* 12.35
66
3.2
074
0
1.3 a 12.8
636
3.0
129
9
1.5 a 14.2
517
2.6
416
7
2.2*
>=12
months 251 15.3705
3.034
83
13.823
1
2.3
364
8
12.79
68
3.0
780
8
13.2
888
2.5
177
8
14.8
566
2.5
478
1
Duration of
HAARTb
< 12
months 9 14.9 1.9 14.0 1.4 11.8 3.9
12.5
556 2.0 15.0 2.8
>=12
months 109 15.9 2.7 14.4 2.3 13.2 2.9
13.8
440 2.5 15.4 2.8
Adherence
To
medication
< 95%
Adherenc
e
35 15.0149 2.6
-1.47 a
13.122
4 2.5
-3.6** 12.89
55 2.4
-.8 a 13.1
343 2.7
-.1.0 a 14.8
358 2.6
-1.4 a
>=95%
Adherenc
e
83 15.6455 2.9
14.436
4 2.2
13.28
18 3.3
13.5
273 2.6
15.3
909 2.6
Prophylacti
c /RX of
opportunist
ic infection
Yes
279 14.7 2.9
3.9**
13.4 2.4
2.4*
12.7 3.0
.6 a
12.9 2.6
1.9 a
14.3 2.5
3.6**
No
115 16.0 3.2 14.1 2.7 12.5 3.5 13.5 3.0 15.4 2.7
a = Non significant,
b = doesn’t fit to the model
*significant at the .05 level
**significant at the .01 level
33
5.5.3. PLHIV Care & Support characteristics
Those that stated to have support from family members for physical care & emotional
care giver had better mean scores for HRQOL scales in psychological domain (mental
health) than those who did not get support. (tdf, 392=2.0 P <0.1) and ( tdf,392=2.6 P <0.1)
respectively. Better emotional care were strongly associated with better mean scores for
the HRQOL in all domains scales than those who were not getting emotional support,
(P<0.05) (table 7). In the same way, those who got treatment supporter have got
improved quality of life in Physical, mental and spiritual health than those who do not
have (P<0.05).
However, having financial support didn’t seem to impart change on all domains of health
related quality of life of PLHIVs (P>0.05 for all domains) (Table 7).
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Table: 8 Relation between psychosocial characteristics with the different HRQOL domain
in PLHIV attending treatment follow up, South Wollo Zone NE Ethiopia, June,
2011
Varia
ble
Cate
gory
Num
ber
Physical Psychological Social Environmental Spiritual Independency
Mea
n
SD t Me
an
S
D
t Me
an
S
D
t Mea
n
SD t Mea
n
S
D
t Me
an
S
D
t
Physic
al care
giver
yes
156 15.1
3.1 0.8 a
13.2
2.7 2.0
* 12.8
3.0 0.6a
13.2
2.8 0.4a
14.5
2.6 0.9
a
13.6 3.0 0.7 a
no
238 15.1
3.0
13.8
2.3
12.6
3.2
13.1
2.7
14.7
2.6 13.8 2.6
Emotio
nal
Car
giver
yes
67 16.3
2.8 3.5** 14.3 2.7 2.6
**
13.4 3.6 3.1*
*
13.9 2.7 2.5** 15.7 2.5 3.6*
*
14.6 2.7 3.1**
no 327
14.9
3.0 13.5 2.4 12.7 3.0 13.0 2.7 14.4 2.6 13.5 2.7
Have
treatm
ent
buddy
yes
184 15.5 3.1
2.4*
13.6 2.7
0. 2
a 12.9 3.0
1.7 a
13. 5 2.8
2.3*
14.7 2.8
0.
3a 14.0 2.8
2.4*
no
210 14. 8 3.0 13.6 2.3 12.4 3.2 12.8 2.6 14.6 2.4 13.4 2.6
Financ
ial
suppor
t
yes
59 15.5 2.9
.97
a
14.0 2.2
1.4
a
12.7 3.2
.2 a
13.16
10 2.6
.1a
14.5 2.4
0.
4a 13.9 2.8
.8 a
no
335 15.1 3.1 13.5 2.5 12.6 3.1 13.1299 2.7 14.7 2.6 13.6 2.7
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5.5.4 Predictors of HRQOL among PLHIV
As it can be noted from the findings of bivariate logistic regression analysis, WHO
staging of being in late clinical stage, having low CD4 count, having financial support &
physical support were not having association with HRQOL of PLHIV and therefore these
variables were not introduced to the multivariate regression. Moreover, sex being
female, marital status being single, ethnicity and religion were primary excluded from
introducing in the model to the multivariate regression as the model fitting test
demonstrate less effect on the dependant variables .
Consequently, in the multivariate regression which controls the undesirable effects of
confounding variables was used by taking all the socio-demographic, psychological &
clinical variables were analyzed . Accordingly, PLHIV on ART medication demonstrate
2.77 times higher total HRQOL as compared to those ART Naïve (AOR = 2.77, 95%
CI: (1.61,4.78)). Younger PLHIV have 2.22 times higher HRQOL as compared to those
age greater than 30 years (AOR = 2.22 , 95% CI: (1.33,3.70). Similarly those in the 2nd
& 3rd income percentiles were   2.95 and 3.68 more likely to have good health related
quality of life (AOR = 2.95, 95% CI: (1.17, 7.42) (AOR = 3.68, 95% CI (1.15, 11.78)
respectively (Table 9).
Also In multivariate analysis after including all predictor variables from socio-
demographic variables in the clinical and psycho-behavioral variables ; adherence to
HAART in greater than 95 % (AOR: 3.43, 95% CI: (1.52,7.70), and being aware of their
HIV status greater than one year (AOR= 2.22,95%, CI (1.33,3.70)) , Having treatment
supporter (AOR = 1.94, 95% CI,  (1.18, 3.19), have emotional Care giver (AOR =,95%
CI, 2.21 (1.15,4.27) and got Prophylactic treatment  for opportunistic infection(AOR =
2.28, 95% CI, (1.29, 4.03) ) were identified as independent predictors of good HRQOL
(Table 10).
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Table 9: Multivariate analysis of Socio-demographic characteristics associated with
HRQOL of   PLHIV in South Wollo zone NE Ethiopia, June, 2011.
Variables HRQOL mean score Crude   OR(95%
CI)
Adjusted
OR (95 % CI)
Less the mean
13.60 ((n=186
(47.2%))
Greater or equal to
the mean
13.60((n=208
(52.8%)
Treatment Category
On ART 42  (35.6% 76 (64.4%) 1.97 (1.27, 3.08) 2.77 (1.61,4.78)
ART Naïve 144 (52.2%) 132 (47.8%) 1 1
Age
19-29 51(35.4%) 93(64.6%) 2.14(1.40, 3.27) 2.22 (1.33,3.70)
>=35 135(54.0%) 115(46.0*) 1 1
Sex
Male 68(43.9%) 87(56.1%) .80  (.53, 1.20) **
Female 118(9.4%) 121(50.6%) 1
Residence
Rural 68 (67.3%) 33(32.7%) 1 1
Urban 118 (40.3%) 175 (59.7%) 3.06(1.90, 4.92) 2.21(1.25, 3.90)
Educational status
Unable to read and
write
69 (62.7%) 41(37.3%)
1 1
Literate 117(41.2%) 167(58.8%) 2.40 (1.53, 3.78) 1.73 (.98,3.08)
Religion
Orthodox 84 (44.2%) 106 (55.8%) 1
Muslim 102 (50.0%) 102 (50.0%) .79 (.53, 1.18) **
Have a job for pay
Yes 137 (44.9%) 168 (55.1%) 1.50 (.93, 2.42) **
No 49 (55.1%) 40 (44.9%) 1
monthly Income
<400 birr 49 (53.8%) 42 (46.2%) 1 1
401-1000 birr 65 (42.2%) 89(57.8%) 1.60 (.95, 2.69 2.95(1.17, 7.42)
>1000 birr 23 (38.3%) 37 (61.7%) 1.88 (.97, 3.65) 3.68(1.15,11.78)
Note: - Insignificant variable in crude analysis was omitted from entering in to the model and not
presented on the table, ** not significant during multivariate analysis, P value < 0.05.
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Table 10: Multivariate analysis of Clinical factors associated with HRQOL of PLHIVs in
South Wollo zone NE Ethiopia, June - 2011.
Variables HRQOL mean score Crude OR(95%
CI)
Adjusted
OR (95 % CI)
<= 13.60 >=13.60
PLHIVs WHO Stage Stage 1 &
2
168 (47.5%) 186 (52.5%) .91 (.47, 1.75 **
Stage 3 &
4
18 (45.0%) 22 (55.0%) 1
Current CD4 Count <=199 24 (57.1%) 18(42.9%) 1.56(.82, 2.98) **
>=200 162 (46.0%) 190(54.0%) 1
Duration of HIV Status
awareness
< 12
months 75(52.4%) 68(47.6%) 1 1
>=12
months
111(44.2%) 140(55.8%) 1.40 (1.01, 2.10) 2.22 (1.33,3.70)
Adherence to ART
(n=118)
> 95%
Adherence
30 (50.8%) 18(31%) 2.36(1.28, 4.46) 3.43 (1.52,7.70)
<=95%
Adherence
29(49.2%) 41 (69%) 1 1
Prophylactic /RX of
opportunistic infection
Yes 144 (51.6%) 135(48.4%)
1.85(1.17,2.90)
2.28 (1.29, 4.03)
No 42 (36.5%) 73 (63.5%) 1
Physical care giver yes 75(48.1%) 81(51.9%) 1.06 (.70 ,1.59) **
no 111(46.6%) 127(53.4%) 1
Emotional Care giver yes 49 (73.1%) 18 (26.9%) 2.88(1.61, 5.15) 2.21 (1.15,4.27)
no 159 (48.6%) 168 (51.4%) 1
Have treatment buddy yes 109 (59.2%) 75 (40.8%) 1.63( 1.09, 2.43)
1.94 (1.18, 3.19)
no 99 (47.1%) 111(52.9%) 1
Financial support yes 23(39.0%) 36(61.0%) .67(.38,1.19) **
no 163(48.7%) 172(51.3%) 1
*Adjusted for socio-demographic variables a Variable(s) entered on step 1: financial, physical,
emotional. Care, treatment, duration, Cd4.numbr, current WHO stage, opportunistic disease Rx,
category, residence, age, Education.
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5.5.5 Multiple Linear regression
Multiple Linear regression was applied to determine the contribution made by each
domain score to explain the observed variance in the general facet. All domains scores
and all socio-demographic clinical & care and support variables that were associated at
binary logistic regression (p<0.05) were entered as independent variables. The
dependent variable was the Overall QOL. The resulting model was statistically
significant, P <0.001, and showed a significant contribution from Environmental Domain
(B=0.251), Social relationships (B=0.143), and Physical domain (B=0.137).
Table 11:  Multiple linear regression analysis: Predictors of health related quality of life
(HIV-QOL)
Variables
Un
standardized
Coefficients
Standardized
Coefficients
t Sig.
95% Confidence
Interval for B
B
Std.
Error Beta
Lower
Bound
Upper
Bound
Environmental Domain .251 .013 .370 18.709 .000 .225 .278
Social Domain .143 .010 .229 14.456 .000 .124 .163
Physical Domain .137 .011 .206 11.781 .000 .109 .152
PSYOLOGICAL
Domain
.136 .014 .183 9.989 .000 .109 .163
Spiritual Domain .123 .010 .181 12.426 .000 .103 .142
Level of Independence
Domain
.123 .011 .179 10.785 .000 .100 .145
Income .128 .040 .048 3.219 .002 .049 .206
Educational Status .001 .021 .001 .048 .962 -.040 .042
Age -.010 .016 -.009 -.657 .513 -.042 .021
Treatment Category -.034 .052 -.009 -.658 .512 -.136 .068
Residence -.045 .056 -.011 -.801 .425 -.156 .066
Treatment Adherence -.089 .049 -.024 -1.820 .071 -.186 .008
a Dependent Variable: Total QOL
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6. DISCUSSION
An advent of ART in Ethiopia since 1991 improves the life of many PLHIV who
otherwise could die. Health-related quality of life is becoming increasingly important
issues associated with HIV disease. Along with clinical indicators of morbidity and
mortality, measures of HRQOL (such as physical functioning, mental health) can help
guide treatment decisions for both patients and providers. This work contributes to the
literature on QOL research in the context of HIV disease and explored the relationship
between QOL and socio-demographic, behavioral and clinical variables.
The six domains that yielded one-factor structures (physical, psychological, level of
independence, social relationships, environmental and spiritual) had good internal
consistency, with Cronbach’s alphas ranging from 0.82 to 0.86. These Cronbach’s
alphas were stronger than those of the WHO quality of life group preliminary study (.45-
.86) and the Brazilian study (.32-.88). It was also higher than the study done in southern
Ethiopia by Amare et. al. which come up with a finding between 0.57-0,85 ( 25, 26).
Therefore the Amharic version of the WHOQOL- HIV instrument had a good internal
consistency to assess the QOL PLHIV. The instrument also demonstrates positive
inter domain correlation indicating the instruments had measured the same concept.
The WHOQOL-HIV instrument was previously reported to have a good reliability and
validity in different cultures worldwide [17, 25]. The mean Overall quality of life &
general health perceptions was 3.61 in this finding It is slightly higher than that reported
from similar studies from other regions. O'Connell and colleagues have described a
mean overall HRQOL & general health perceptions score (measured by WHOQOL) of
3.2 ± 0.88 for a sample of 590 HIV-infected persons from six culturally diverse sites in
Australia, Brazil, India (two sites), Thailand and Zimbabwe and a study done in Estonia
mean for general health perception (2.90 ± 0.84) this difference might be related to the
difference in method Sample characteristics and location of the study.
The mean HRQOL score for the whole sample in our finding is 13.61 (SD= ±2.09),
nearly half 47.2% of all respondents (144 (52.2%) of ART naïve and 42(35.6%) ART
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group did have poor quality of life .This finding was in agreement with the study done in
libanon but is higher than a study done in Indonesia (37.4%) had good quality of life,
and 62.6.8%) had poor quality of life (27). However, these studies was used
convenience sampling and relatively small sample size. This study is in a contrast to a
study by Aeamlaor (2001) who found 92.2% had a good QOL( WHO HIV 100) since
they were cared for by social welfare organizations and study in USA & Estonia (18,
20).
In this study, the mean score was highest and similar in the spirituality/religion/personal
beliefs & physical health with other findings indicating a better QOL in these domains.
However, the mean score for social, environmental & Psychological domains were at
the intermediate level. The same finding were documented by Ebisabete et al. (2007) in
Sao polo brazil (26) and a study done in Kogi state, Nigeria , the results showed that
mean scores for social relationships and environment domains fell in the intermediate
level, a result observed to be similar with the present study (14). The resulting low level
QOL in the social relationships domain could reflect stigmatization and discrimination
faced by the participants and issues like personal relationships, sexual activities, and
social support of PLHIV can have a negative effect in the social relationship domain.
On multivariate analysis, the subscales that were most predictive of HRQOL were
Environmental health, physical functioning and social functioning. These subscales
contribute to HRQOL and focus predominantly on access to health care, transportation
& management of pain, Social functioning & inclusion (Non stigmatization) and absence
of pain etc…the resulting model was statistically significant, P <0.001, and showed a
significant contribution from environmental domain (B=0.251), Social relationships
(B=0.143), and Physical domain (b_0.321) domains. Unlike this study, a research done
by Maria .et.al. among Portuguese PLHIV, showed a significant contribution from
Psychological domain (b= 0.256), Level of independence (b=0.204), Social relationships
(b=0.143), and Environment domains (b=0 .321).These domains explained 63% of the
total variance; the Psychological domain contributed most highly to the observed
variance, and Social relationships presented the lowest contribution. The difference may
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be due to Portuguese patients may have better access to treatment & transportation
and housing (32)
In this study those in the 2nd & 3rd income percentiles were 2.95 and 3.68 more likely
to have good health related quality of life (AOR = 2.95, 95% CI: (1.17, 7.42) (AOR =
3.68, 95% CI (1.15, 11.78) respectively than the 1st income percentile group. Education
& Age were predictors of HRQOL. Similarly Eriksson et al.’s study in Sweden & Marzieh
Nojomi study in Iran demonstrate significant relationship between higher level of
education, being employed, and better quality of life , our findings are consistent with
previous research, which has demonstrated that employment (and higher income) is
associated with a better QOL among PLHIV. Employment may also provide resources,
which buffer the effects of the stress of HIV infection and thus serves to maintain a
sense of quality of life [21].Therefore, providing employment, financial self-sufficiency,
and financial assistance for patients, particularly for women affected by the disease, and
making appropriate job safety for patients are the interventions causing promotion in
quality of patients’ life (20 21, 28).
The significant impact of clinical stage of disease on the quality of patients’ life reflects
the disabling nature of the disease which affects various aspects of patients’ quality of
life seriously. This has been demonstrated in many longitudinal studies (2, 5). Because
of the cross-sectional nature of the study, this study didn’t determine baseline &
progressive CD4 count. Hence, it was difficult to adjust treatment effects for important
clinical predictors, such as CD4 counts, and disease stage, which are known to be
associated with HRQOL as a result CD4 count & WHO staging were not associated with
HRQOL in this study similar finding was observed by Chenglong Liu et al in longitudinal
study among PLHIV women in U.S.A identified biological (CD4+ cell counts and HIV
viral load) variables were not significantly associated with QOL changes from baseline.
Some researchers argued and explained that, this phenomenon might be explained by
the weak associations between these biological variables and QOL (31)
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We were also interested in the relationship between antiretroviral therapy and HRQOL.
Persons with HIV disease (ART Naïve) have demonstrated low HRQOL score than
those on ARV treatment. Accordingly, PLHIV on ART demonstrate mean score HRQOL
14.3 (SD=+1.7) Vs 13.3 (SD= +2.2) for ART naïve group (tdf 392 = 4.39, P<o.oo1). In
bivariate analysis the association was 2.77 times higher HRQOL as compared to those
ART Naïve (AOR = 2.77, 95% CI: (1.61, 4.78). Literatures agreed that Quality of life can
be altered by both the immediate effects and the longer-term consequences of
antiretroviral treatment (12, 16, and 22).
Despite concerns that self-report may overestimate; several studies have demonstrated
a strong association between self-reported adherence and both virological and
immunological outcomes in HIV, Self-reported adherence has also been shown to
correlate with plasma concentrations of antiretroviral medications (31). In this  study on
multivariate analysis adherence to HAART in greater than 95 % (AOR: 3.43, 95% CI:
(1.52,7.70), and being aware of HIV status greater than one year (AOR= 2.22,95% CI,
(1.33,3.70)) , Having treatment buddy (AOR = 1.94, 95% CI,  (1.18, 3.19), have
emotional Care giver (AOR =,95% CI, 2.21 (1.15,4.27) were identified as independent
predictors of good HRQOL in the clinical & behavioral variables. The same finding was
also established from studies in south Ethiopia by Kebede etal.  Participants treated for
>12 months had higher mean scores for all domains than those who had been treated
for ≤12 months. Likewise, Participants adhering to treatment had better mean scores for
all scales except ‘role physical,’ ‘bodily pain’ and ‘vitality’ in comparison to those who
were not adherent (23, 30). However, the possibility that one or more HRQOL
dimensions are causes of differences in adherence (adherence causes QOL or QOL
causes adherence) cannot be demonstrated, given that this is a cross-sectional (not
longitudinal) study.
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7. Strength & Limitation of the study
7.1 Strength of the study
1. Tests the validity of the Amharic version of WHO HRQOL- HIV bref , so other
researches can Use it.
2. The original data collection tool is a standardized tool and all the data coding,
transforming and analysis procedures was made based on WHO manual . This
will have added value in ensuring the quality of data with and the comparability of
the research others.
7.2 Limitations of the study
Due to cross-sectional nature of the study this study was not able to assess it may fail
the ability to detect changes over time for some variables.
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8. Conclusion
 The level of total quality of life and the six domain of health related quality of life
are moderately low compared to many findings.
 Of all domains, the social, environmental & Psychological domains are at the
lowest level and significantly affect the overall QOL of PLHIVs in the study area.
 Being on ART , income, good adherence to HAART , being aware of HIV status
greater than one year , have emotional Care giver, Having treatment  supporter ,
got Prophylactic treatment  for opportunistic infection & education, were identified
as independent predictors of good HRQOL.
This study also showed that the Amharic version of the WHO HRQOL HIV- bref
is a valid and reliable instrument to assess the HRQOL of PLHIV.
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9.  Recommendation
 For Clinicians
Clinicians need to be aware of the factors & dimensions that affect QOL of
PLHIVs and need to asses and modified early in the course of an HIV/AIDS
patient’s treatment plan so as to get secession HIV care & treatment.
Equal to treatment care, educational and counseling programmes for PLHIV and
their family members need to be enhanced.
 For Policy Makers
In addition, social interventions policy makers seek to enhance the economic and
employment opportunities for PLHIVs. Different employment & income
generating schemes designed and provided specially for PLHIV with low income.
In each ART site there is a need to assign social workers and adherence
supporter side by side to clinical care givers
NGOs and GOs Institutions need to strengthen & harmonize efforts  for
comprehensive  care & support of PLHIV
 For researchers
Further investigation using longitudinal design and/or qualitative study is
recommended; hence it might clarify how QOL evolves over time and might also
allow examination of the direction of a relationship between HIV-specific features
(e.g., HIV progression; response to new therapeutic regimes) and HRQOL out
comes.
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11. ANNEXES
Annex I
Conceptual framework
 Socio demographic
characteristics: -
 Age, Sex, Marital Status,
Religion, Availability of
paid job and Monthly
income
 Culture & Economy
Behavioral variables
 Stigma (perceived
stigma & Actual
stigma)
 Adherence
Clinical variables
 WHO clinical
stage of the disease,
 HIV helper cell
count (CD4+) counts,
 Presence of
opportunistic infection
QOL
 Physical Health
 Psychological
Health
 Social relationship
 Spiritual health
 Level of
independence
 Environmental
Health
 Disease
 Treatment
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Annex II:  ENGLISH QUESTIONNAIRE
UNIVERSITY OF GONDAR COLLEGE OF MEDICINE AND HEALTH SCIENCES
SCHOOL OF PUBLIC HEALTH
QUESTIONNAIRES TO ASSESS QUALITY OF LIFE AND ASSOCIATED FACTORS AMONG PEOPLE
LIVING WITH HIV/AIDS IN SOUTH WOLLO ZONE, NORTH EAST ETHIOPIA
Hello! My name is -------------- I am MPH student in university of Gondar. The purpose of
this questionnaire is to gather information on quality of life and associated factors
among people living with HIV/AIDS in south Wollo zone, north east Ethiopia.
I have identified you as a study participant hoping that you would be willing to help
provide me with some information. I have several questions which I would like to ask
you, if you have the time and are willing. The questionnaires include socio demographic
factors, quality of life instruments, and clinical factors.  All information you provide was
kept confidential. I will not include any identifiers, such as your name or exact address.
Only honest answers would contribute to improvement of health planning. Your role in
the success of the research is important and I appreciate your contribution to the
research. You can with draw at any time during the interview if you feel uncomfortable.
Would this be okay with you?
I understood about the advantage of the research and the roles I will have in the
research. I have agreed to participate in the research.
Yes                                    No
001. Questionnaire Code __________
002. Address/ kebele -----------------
003. Category   __________ART __________ ART NAVIE
Date of data collection----------------------------------------
Name of data collector--------------------------------------- signature--------------------
Name of supervisor------------------------------------------- signature-------------------
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SECTION 1. RESPONDENT’S BACKGROUND INFORMATION
S.No Questions Alternatives Code Skipping
101 Residence 1. Rural
2. Urban
102 Sex  Male
 Female
103 Age in
completed years
Age: ___________ years
104 What is your
ethnicity?
1. Amhara
2. Tigrie
3. Oromo
88.Others, please
specify_______
105 Your educational
status
1. Illiterate
2. read and write
3. elementary 1st cycle 1-4
4. elementary 2nd cycle 4-8
5. high school 9-10
6. preparatory
7. TVT
8. college or university
106 What is your
current religion?
1. Orthodox
2. Catholic
3. Protestant
4. Moslem
88. Other (specify)  __________
107 What is your
current marital
status?
1. Never married
2. Married
3. Divorced
4. Separated
5. Widowed
108 Are you currently
have a job for pay
1. Yes
2. no
109 What is your
monthly income
__________________ Birr
99. I don’t have
110 What is your
occupation?
1. Civil servant
2. Housewife
3. Merchant
4. Driver
5. Farmer
6. Daily laborer
7. Housemaid
88. Others, specify
___________
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SECTION II. Support & Behavioral characteristics
S.No Questions Alternatives Code Skipping
201 Are you currently
receiving any
financial or
material  support
or grant
1. Yes
2. No
203
202 If yes to q 201
As per your
perception is the
support
adequate to lead
your life
1. Yes
2. No
203 Do you have
physical care
giver
1. Yes
2. No
205
204 Who gave you
the support
1. Family members
2. Outside family members
3. Orphan &other care centers
4. Others please specify ----------
204 Do you have
emotional care
giver or have
you had
emotional
assistance
1. Yes
2. No
205 have you have
treatment buddy
1. Yes
2. No
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SECTION III. Clinical  parameters filled by clinician from
the patients card
S.No Questions Alternatives Code Skipping
301 Adherence to
dose of ARVs
over the last
one
month
1. Good
2.Fair
3.poor
302 Adherence to
schedule 1. Never
2 .Sometimes
3 Most of the time
4. Always
303 Month of
knowing your
HIV status
____________ months
304 Most recent
Cd4 count _____________cells/mm3
305 Most recent
Cd4 count
1.WHO stage  one
2.WHO stage two
3. WHO stage three
4.WHO stage four
306 Prophylaxis
treatment for
opportunistic
infection ?
1. Yes
2. No
55
Part IV : Health Related Quality of Life (WHOHRQA) questionnaire
Code Question Very
Poor
Poor Neither
poor nor
Good
Good Very
Good
401 How would you rate your quality of life
Code Question Very
Dissatisfied
Dissatisfied Neither
Satisfied
Nor
Dissatisfied
Satisfied Very
Satisfied
402 How satisfied are
you with your
health
The Following ask about how much you have experienced certain things in the last two
weeks
Code Question Not
at
all
A
little
A
moderate
amount
Very
Much
An
Extreme
Amount
403 To what extent do you feel that
physical pain prevents you from doing
what you need to do?
404 How much are you bothered by any
physical problems related to your HIV
infection?
405 How much do you need any medical
Treatment to function in your daily life?
406 How much do you enjoy life?
407 To what extent do you feel your life to
be meaningful?
408 To what extent are you bothered by
people blaming you for your HIV status
409 How well are you able to concentrate?
410 How safe do you feel in your daily life?
411
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How healthy is your physical
environment?
412 Do you have enough energy for
everydayLife?
413
Are you able to accept your bodily
Appearance?
Code Question Not
at
all
A
little
A
moderate
amount
Very
Much
An
Extreme
Amount
414 Have you enough money to meet your
needs
415 To what extent do you feel accepted
by thePeople you know?
416
How available to you is the
information thatyou need in your day-
to-day life?
417
To what extent do you have the
opportunityFor leisure activities?
Very
poor
poor Neither
poor nor
good
Good Very
good
418
How well are you able to get around?
Code Question Very
dissatisfied
Dissatisfied Neither
satisfied nor
dissatisfied
Satisfied Very
Satisfied
419 How satisfied are you
with your sleep?
420 How satisfied are you
with your ability to
perform your daily living
activities
421 How satisfied are you
with your capacity for
Work?
57
422
How satisfied are you
with yourself?
Code Question
423 How satisfied are you with your personal
Relationships?
424 How satisfied are you with your sex life?
425 How satisfied are you with the support you
get from your friends?
426
How satisfied are you with the conditions
ofYour living place?
427 How satisfied are you with your access
tohealth services?
428 How satisfied are you with your transport?
The following question refers to how often you have felt or experienced certain things in the last
two weeks.
code Questions Never Seldom Quite
often
Very
often
Always
429 How often do you have negative feelings
such as blue mood, despair, anxiety,
depression?
430 How much do you fear the future?
431 How much do you worry about death?
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ANNEX III- Amharic Questionnaire
የሚከተሉት ጥያቄዎች ስለጤናዎ ስለአኗኗርዎና ሌሎች ሂዎትዎትን በተመለከተ የሚጠይቁ
ናቸው፡፡ እያንዳንዱጥያቄ ከምርጫቸው ጋር አነብልዎታለሁ፡፡ እባክዎ ለእረስዎ የተሰማዎትን
አንዱን ብቻ ይምጡ በመልስዎ እርግጠኛ ካልሆኑ መጀመሪያ ያሰቡትን በአብዛኛው ትክክል ነው፡፡
እባክዎ ከአእምሮ የወደፊት ተስፋዎትን ደስታዎትን አኗኗርዎትን እና ሌሎች ትኩረት
የሚሰጡባቸውን ጉዳዮች ይሰቡ ባለፉት 4 ሳምንታት ስለህይዎትዎ አንዳንድ ጥያቄዎች
አቀርብልዎታለሁ፡፡ በተቻለዎት መጠን ጥያቄዎችን ለመመለስ ይሞክሩ፡፡ ለዚህ ጥናት መልስ
በመስጠት ስለተባበሩን አመሰግናለሁ፡፡
የመለያ ቁጥር __________________
የካርድ ቁጥር _________________
የጥናት መለያ ቁጥር _________________
ክፍለ አንድ - አጠቃለይ መረጃ
ተቁ ጥያቄ አማራጭ ኮድ
101 የመኖሪያ አድራሻ 1. ገጠር
2. ከተማ
102 ፆታ 1.ወንድ
2. ሴት
103 እድሜ ------- ዓመት
104 ብሔር 1. አማራ
2. ትግሬ
3. ኦሮሞ
4. ሌላ ባክዎን  ይግለፁ-------
105 የትምህርት
ደረጃዎ
1. ማንበብ መፃፍ የማይችል
2. ማንበብ መፃፍ የሚችል
3. አንደኛ ደረጃ
4. ክፍተኛ ሁለተኛ ደረጃ
5. ኮሌጅ ወይም ዩኒቨርሲቲ
106 ኃይማኖት 1. ኦርቶዶክስ
2. ካቶሊክ
3. ኘሮቴስታንት
59
4. ሙስሉም
5. ሌላ ካለ ይጠቀስ---
107 የትዳር ሁኔታ 1. የላገባ/አግብቶ የማያውቅ/
2. ባለትዳር
3. አግብቶ/  / የፈታ /ች/
4. የሞተባት
5. ሌላ ይጥቀሱ------------
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ክፍያ የሚያስገኝ
ስራ በመስራት ላይ
ነህ/ሽ/
1. አዎ ወደ ቁጥር 1ዐ
2. አይደለም /ቁጥር 11/
109 የወርሃዊ ገቢ ምን
ያህል ነው?
______________ብር
110 ሙያ /ስራ/ 1. የመንግስት ሰራተኛ
1. የቤት መቤት
2. ነጋዴ
3. ገብሬ
4. የቀን ሰራተኛ ወይም የቤት
ሰራተኛ
5. ሹፊር
6. ሌላ ካለ ይጠቀስ---------
ክፍል-2 ድጋፍና  ክብካቤን የሚመለከቱ ጥያቄወች
ተቁ ጥያቂ አማራጮች ኮድ
201 በአሁኑ ሰአት የገንዘብ
ወይም የቁሳቁስ ድጋፍ
አለዎት?
1. አዎ
2. አላገኝም
202 ለጥያቂ 201 መልስዎ
አዎ ከሆነ የሚያገኙት
ድጋፍ ኑሮዎትን
ለመምራት በቂ ነው?
1. አዎ
2. . አይደለም
203 አካላዊ ክብካቤ
የሚሰጠዎት አለ?
1. አዎ
2. የለም
3. አልፈልግም
205
204 ለጥያቄ ቁጥር 203
መልሰዎ አዎ ከሆነ
ክብካቤ የሚሰጠዎት
ማን ነው?
1. የቤተሰብ አባላት
2. ከቤተሰብ አባላት ውጭ
3. ሌላ ይጠቀስ ______
205 መንፈሳዊ ድጋፍ
የሚያደርግልዎት አለ?
1. አዎ
2. የለም
206 የህክምና ድጋፍ
የሚያደርግለዎት አለ?
1. አዎ
2. የለም
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ክፍል 3 የህክምና መረጃዎችን በተመለከተ - በጤና ባለሙያዎች የሚሞላ
ተ/ቁ ጥያቄ አማራጭ ኮድ
301 በአለፈው አንድ ወር
የመድኃነት
አወሳሰድ በተመለከተ
1 .ከፍተኛ ከ 95 % በላይ
መድሀኒቱ
በትክክልተወስዷል::
2 መካከለኛ ከ8ዐ-95
3 ዝቅተኛ ከ 8ዐ% በታች
መድኃኒቱን
ተወስዷል
302 ቀጠሮን በትክክል
የመከታተል ሁኔታ
1. በፍጽም አያክብርም
2. አልፎ አልፎ
3. አብዛኛው ቀጠሮን ያከብራል
4. ሁልጊዜ ቀጠሮ ያከብራል
ታከብራለች
303 ኤች አይቪ
ተመርምረው
ራስዎን ካወቁ ስንት
ጊዜ ሆነዎ
_________________ወራት
304 የሲዲ 4 ሴሎችን
በተመለከተ
የመጨረሻ ወይም የቅርብ ጊዜ
የሲዲ 4 ሴሎች  መጠን
_______
3ዐ5 በአለም የጤና ደረጂት
(WHO) የኤች አይቪ
ደረጃ መሰረት
ህመምተኛው አሁን
ያለበት ደረጃ
1.ደረጃ አንድ
2. ደረጃ ሁለት
3. ደረጃ ሁለት
4. ደረጃ አራት
306 ህመምተኛው ቅድመ
መከላከያ መድሀኒት
(
ኘሮፍላክሲስ)እየወሰደ
1. አዎ
2.አይደለም
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ነው
ክፍል 4 - አጠቃላይ የጤንነት ሁኔታ ጥያቄዎች
በጣም ያመኛል አልፎ አልፎ ያመኛል መካከለኛ (ደሕና
ነኝ)
ጥሩ ነው በጣም ጥሩ
1 ጤና አንድት
ነው
1 2 3 4 5
አዎ አይደለም
2 በአሁኑ ሰአት ታምሜያለሁ ብለው
ያስባሉ?
1 2
ምን
ም
በጥቂቱ መካከለኛ በጣም እጅግ
በጣም
3 በአካላዊ ህመም ምክንያት ያሉበትን ስራ ለመስራት ምን
ያህል አዳጋች ነው ብለው ያስባሉ?
1 2 3 4 5
4 ኤች አይ ቪ በደምዎ ውስጥ በመኖሩ ምክንያት በአካልዎ የሚታዩ
ለውጦች ምን ያህል ያስጨንቅዎታል?
1 2 3 4 5
5 የእለት ከእለት ተግባርዎትን ለማከናዎን ምን ያህል የህክምና
አገልግሎት ያስፈልጋል ብለው ያስባሉ?
1 2 3 4 5
6 በህይዎትዎ ምን ያህል ደስተኛ ነዎት? 1 2 3 4 5
7 ምን ያህል ትርጉም ያለው ህይወት እየኖርኩ ነው ብለው ያስባሉ? 1 2 3 4 5
8 ኤች አይ ቪ በደምዎ ውስጥ በመኖሩ ምክንያት ምንያህል
የጥፋተኝነት ስሜት ይሰማዎታል ?
1 2 3 4 5
ምንም በጥቂቱ መካከለኛ በጣም እጅግ
በጣም
9 ለነገሮች ምን ያህል አትኩሮት መስጠት
ይችላሉ?
1 2 3 4 5
10 በእለት ከእለት ኑሮዎ ምቾት ወይም ደህንነት
ይሰማዎታል?
1 2 3 4 5
11 የመኖሪያ አካባቢዎ ምን ያህል ለጤና አመች 1 2 3 4 5
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ነው?
ምንም በጥቂ
ቱ
መካከለ
ኛ
በጣም እ
ጅ
ግ
በ
ጣ
ም
12 በእለት ከእለት ኑሮዎን ለማከናዎን በቂ ጉልበት
አለዎት?
1 2 3 4 5
13 ከህመም ጋር ተያይዞ የሚከሰቱ የአካል ወይም
የሰውነት ለውጦች (የሰውነት
መቀነስ፤መቁሰል፤ወዘተየመሳሰሉት) ምን ያህል
ተቀብለውታል?
1 2 3 4 5
14 መሰረታዊ ፍላጎትዎትን ለማሟላት በቂ ገንዘብ
አለዎት?
1 2 3 4 5
15 በሚያውቋቸው ሰዎች ምን ያህል ተቀባይነት አለኝ
ብለው ያምናሉ?
1 2 3 4 5
16 በእለት ከእለት ተግባርዎ የሚያስፈልግዎን መረጃ
ምን ያህል ያገኛሉ ?
1 2 3 4 5
17 ምን ያህል እስዎን ያዝናናሉ? 1 2 3 4 5
በጣም
ዝቅተኛ
ዝቅተኛ መካከለኛ ጥሩ በጣ
ም
ጥ
ሩ
18 እንደፈለጉ መንቀሳቀስ ይችላሉ? 1 2 3 4 5
19 ምን ያህል በእንቅልፍዎ ይረካሉ ? 1 2 3 4 5
20 የእለት ከእለት ተግባርዎን ለማከናዎን ባለዎት
ችሎታ ምን ያህል ይለካሉ?
1 2 3 4 5
21 ባለዎት የመስራት አቅም ም ያህል ይረካሉ? 1 2 3 4 5
22 በራስዎ ምን ያህል ደስተኛ ነዎት? 1 2 3 4 5
በጣም
ደስተኛ
አይደለሁም
ደስተኛ
አይደለሁም
መካከለኛ
ደስታ አለኝ
ደስተኛ
ነኝ
በጣም
ደስተኛ ነኝ
23 ከሌሎች ሰዎች ጋር ባለዎት ግንኙነት ምን
ያህል ደስተኛ ነዎ?
1 2 3 4 5
24 በወሲብ ህይዎትዎ ምን ያህል ደስተኛ ነዎት? 1 2 3 4 5
25 ከጓደኞችዎ በሚያገኙት ድጋፍ ምን ያህል
እረክተዋል?
1 2 3 4 5
26 በመኖሪያ ቦታዎና አካባቢዎ ባሉ ሁኔታች ምን
ያህል ደስተኛ ነዎት?
1 2 3 4 5
27 ባለው የጤና አገልግሎት አቅርቦት ምን ያህል
እረክተዋል?
1 2 3 4 5
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28 ባለው የመጓጓዣ አገልግሎት ምን ያህል ደስተኛ
ነዎት?
1 2 3 4 5
በፍጹም በጥቂት አንዳንድ
ጊዜ
በአብዛኛ
ው ጊዜ
ሁልጊዜ
29 ጥሩ ያልሆኑ ስሜቶች ለምሳሌ ድብርት፤
ጭንቀት፤ ፍርሃት፤ መፍዘዝ፤ ተስፋ መቁረጥ፤
የመሳሰሉት ምን ያህል ተከስቶቦዎታል?
5 4 3 2 1
ምንም በጥቂቱ መካከለኛ በጣም እጅግ በጣም
30 ስለወደፊቱ ምን ያህል ይፈራሉ? 1 2 3 4 5
31 ስለመሞት ምን ያህል ይጨነቃሉ? 1 2 3 4 5
ስለትብብዎ በጣም እናመሰግናለ
Annex- IV:  Information Sheet and Consent Form
Title of the Research Project; Assessment of quality of life and
associated factors among adult people living with HIV/AIDS in south wollo
zone, North east Ethiopia
Name of Principal Investigator: Askal Demssie
Name of the Organization: School of Public Health, Gondar College of Medicine and
Health Sciences, University of Gondar.
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Name of the Sponsor: University of Gondar
Introduction: This information sheet and consent form is prepared to explain the
purpose of this research in order to get your willingness to participate in the study. The
main aim of this research project is to assess the quality of life and associated factors
among people living with HIV/AIDS in south wollo zone, Ethiopia.
The research team includes principal investigator, six nurses, two Supervisors and two
advisors from University of Gondar.
Purpose of the Research Project: The main aim of this study is to assess quality of
life and associated factors among people living with HIV/AIDS, who came for chronic
care and treatment, in south wollo zone. As this will provide valuable information and
input for devising strategy and clinical guide line at ART treatment site
Procedures: In order to assess the quality of life and associated factors among people
living with HIV/AIDS we invite you to   participate in the project. If you are willing to
participate in the project you understand and sign the consent form .then, you will
requested to give your response by the data collectors. Study participants are people
living with HIV/AIDS who came for chronic care and treatment in south wollo zone
during the study period and who are selected by systematic random sampling
technique.
Risk and /or Discomfort: By participating in this research project you may feel that it
has some risk or discomfort but there is no risk or discomfort unless it will take about 15
to 20 minutes of your time.
Anticipated Benefits:  If you are participating in this project, the output of the study will
have both direct and indirect benefit to you, as you and your families will use the service
in the future.
Sharing of new findings
The investigators will analyze the information from the survey. They will give the results
of the survey to all stake holders who are working in the area of HIV/AIDS care and
treatment.
Incentives/Payments for Participating: You will not be provided any incentives or
payment to take part in this project.
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Confidentiality: The information collected from you was kept confidential. It was stored
in a file using codes and your name will not be mentioned in recording or data analysis.
And it will not be revealed to anyone except the principal investigator. In addition it was
used only for this particular research but not other purposes.
Right to Refusal or Withdraw: You have the full right to refuse from participating in
this research. You have also the full right to withdraw from this study at any time, if you
have any inconvenience. You will not deny the right of care for not participating.  You
can ask the questions for any ambiguity.
Person to contact: This research project was reviewed and approved by the
institutional review board of school of public health, university of Gondar. If you want to
know more information, you can contact the following individuals and you may ask at
any time you want.
1. Askal Demssie
Mobile: +251911014874 / e-mail: askald21@gmial.com
2. Dr. Belaynew Wassie, University of Gondar, School of Public Health, College of
Medicine and Health Sciences,
Mobile: +251918778268
e-mail :bwassie@gmail.com
3. Prof. Mengesha Admasu, University of Gondar, School of Public Health, College of
Medicine and Health Sciences,
e-mail :kal_meng@yahoo.com
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ANNEX VI   Amharic version information Sheet and Consent Form
የመረጀና የስምምነት ዉል ፎርም
የምርምር ፕሮጄክቱ ርዕስ - በደቡብ ወሎ ዞን በሚገኙ የኤች.አይ.ቪ ቫይረስ በደማቸው ውስጥ ያለ
የፀኤች.አይ.ቪ ህክምና አገልግሎት ተጠቃሚወችን የጤንነት ሁኔታ መዳሰስ
የዋና ተመራማሪዉ ስም - አስካል ደምሴ
የድርጅቱ ስም ፡- በጐንደር ዩኒቨርሲቲ ህክምናና ጤና ሳይንስ ኰሌጅ የህብረተሰብ ጤና አጠባበቅ ትምህርት ቤት
ወጭዉን የሚሸፍነዉ አካል፡- በጐንደር ዩኒቨርስቲ ህክምናና ጤና ሳይንስ ኰሌጅ የህብረተሰብ ጤና አጠባበቅ ትምህርት
ቤት
መግቢያ፡- ይህ መረጃና ስምምነት የተዘጋጀበት ዋና አላማ በምርምር ፕሮጀክቱ የሚሳተፉ የምርምር ፕሮጄክቱ አባላት ስለ
ፕሮጀክቱ እንድያብራሩበት ታስቦ ነዉ፡፡ የጥናቱ ቡድንም ስድስት ድፕሎማ ያላቸዉን ነርሶች፣አንድ ድግሪ ያለዉን
ተቆጣጣሪና ሁለት አማካሪዎችን ከጐንደር ዩኒቨርሲቲ ያከተተ ነዉ፡፡
ጥናቱ የሚካሄድበት ምክንያት:- የፕሮጀክቱ ዋና አላማ በደቡብ ወሎ ዞን የሚገኑ የኤች.አይ.ቪ ቫይረስ በደማቸው ውስጥ
ያለ የኤች.አይ.ቪ ህክምና አገልግሎት ተጠቃሚወችን የጤንነት ሁኔታ የዳሰሳ ጥናት ለማድረግ ሲሆን በተጫማሪም በጥናት
ላይ የተመሠረተ የጤና ፖሊሲ ለማዉጣት እንደምያግዝ የታመነበት ነዉ፡፡
አተገባበር: በደቡብ ወሎ ዞን የሚገኑ የኤች.አይ.ቪ ቫይረስ በደማቸው ውስጥ ያለ የኤች.አይ.ቪ ህክምና አገልግሎት
ተጠቃሚወችን የጤንነት ሁኔታ ለመዳሰስ በተዘጋጀዉ ጥናት ድርሻ እንድኖሪዎ ጋብዘነዎታል፡፡በፕሮጄክቱ ለመሳተፍ
ፈቀዴኛ ከሆኑ ሊፈርሙ ይገባል፡፡ከዚያም በመረጃ ሰብሳቢዎች ምላሽዎን እንድሰጡ ይጠየቃሉ፡፡በዚህ ጥናት እንድሳተፉ
የተመረጡት በናሙና አወሳሰድ ስልት ነዉ፡፡የሚሰጡት መረጀ በአጠቃለይና የጥናቱ ዉጤት በተናጠል ማንም በማያገኛዉ
መልኩ በመለያ ቁጥር ሚስጢራዊነቱ የተጠበቀ ይሆናል፡፡
ሊገጥም የምችል ችግር ወይም አለመመቸት፡-በዚህ ጥናት በመሳተፍዎ ምንም አይነት የሚደርስብዎ ችግር የለም፡፡
መጠይቁን ለመሙላት የተወሰነ ሰአት (15-20 ደቂቃ) ሊወስድበዎ ይችላል ነገር ግን ይህ ጥናት ለወደፊቱ ለዕርስዎና
ለህብረተሰቡ ካለው ጥቅም አኳያ ይህ ብዙ አይደለም:፡ ስለዚህ የእርስዎ መልስ ክፍተቱን ለማሳየትና ለማሻሻል ጠቃሚ
ግብዓት ነዉ:፡
ጥቅሞች፡- በዚህ ምርምር ስላተሳተፉ ለእርስዎ በቀጥታ ወይም በተዘዋዋሪ ጥቅም ይኖረዎታል፡፡ ምክንያቱም ጥናቱ
የኤች.አይ.ቪ ቫይረስ በደማቸው ውስጥ ያለ የኤች.አይ.ቪ ህክምና አገልግሎት ተጠቃሚዎችን የጤንነት ሁኔታ ለማሻሻል
ያለመ በመሆኑ እርስዎና ቤተሰብዎ የአገልግሎቱ ተጠቃሚ ይሆናሉና፡፡
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ለመሳተፍ ጥቅማጥቅም/ክፍያ: በዚህ ጥናት በመሳተፍዎ ምንም ክፍያ አይሰጥዎትም፡፡
ሚስጢራዊነት፡-ከዚህ ምርምር ፕሮጀክት የተሰበሰበ መረጀ ምስጢራዊ ይሆናል፣ስለ እርስዎ የተሰበሰቡት መረጀዎች ስምዎ
ሳይጸፍበት በሚስጥር ይያዛል ይህም ከዋና ተመራመሪዉ በስተቀር ማንም እዳያዉቀዉ ያደርጋል፡፡
ዕንቢ የማለት ወይም የማቋረጥ መብት፡-በዚህ ምርምር የመሳተፍም ሆነ ያለመሳተፍ ሙሉ መብት አሎት፡፡ጥያቄዎቹን
ሙሉም ሆነ በከፊል መልስ አለመስጠት ይችላሉ፡፡ይህ ደግሞ ማንኛዉንም የጤና አገልግሎት ከማገኛት
አያግድወትም፡፡እንድሁም በማንኛዉም በፈለጉ ሰዓት ያለምንም መቀጮ የማቋረጥ ሙሉ መብት አለዎት::
ሊያገኙአቸዉ የሚችሉአቸዉ ሰዎች:- ይህ የምርምር ፕሮጀክት በጐንደር ዩኒቨርሲቲ የጥናትና ምርምር ስነ-ምግባር ኮሚቴ
ተከልሶ ይጸድቃል::ተጨማሪ መረጃ ማወቅ ከፈለጉ የኮሚቴዉን አባላት ከዚህ በታች በላዉ አድራሻ ማግነት ይችላሉ፡፡ጥያቄ
ከለዎት ከሚከተሉት ግለሰቦች ማናቸዉንም በፈለጉ ሰዓት መጠየቅ ይችላሉ፡፡
 አስካል ደምሴ፡ : ስልክ- +251911014874 /
e- mail: askald21@yahoo.com
 ዶ/ር በላይነው ዋሴ ፡በጐንደር ዩኒቨርሲቲ ህክምናና ጤና ሳይንስ ኰሌጅ የህብረተሰብ ጤና አጠባበቅ ትምህርት
ቤት
ስልክ- +251918778268
e-mail :bwassie@gmail.com
ፕሮፌሰር መንገሻ  አድማሱ ፡በጐንደር ዩኒቨርሲቲ ህክምናና ጤና ሳይንስ ኰሌጅ የህብረተሰብ ጤና አጠባበቅ ትምህርት
ቤት
e-mail :kal_meng@yahoo.com
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ጐንደር ዩኒቨርሲቲ የህክምናና ጤና ሳይንስ ኰሌጅ የሕብረተሰብ ጤና አጠባበቅ ትምሕርት ቤት
በጐንደር ዩኒቨርሲቲ የህክምናና ጤና ሳይንስ ኰሌጅ በሕብረተሰብ ጤና አጠባበቅ ትምሕርት ቤት የኤች.አይ.ቪ ቫይረስ
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